Position history for Boston Trust Walden Corp's holdings in CHEMED CORP NEW
Boston Trust Walden Corp holds 205,197 shares of CHE (CHEMED CORP NEW), worth $77.5M as of 2026-Q1. The position was decreased (-7.3% shares). CHE represents 0.6% of Boston Trust Walden Corp's portfolio.
Current Value
$77.5M
Current Shares
205,197
Total Value Change
-$42.6M
Total Shares Change
-16,243
Other major holders of CHE: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 205,197 |
-7.3% |
| $77.5M |
| 0.6% |
| $424.16 |
0 |
| 2025-Q4 | Decreased | 221,241 | -5.6% | $94.7M | 0.7% | $430.82 | 0 |
| 2025-Q3 | Decreased | 234,466 | -5.2% | $105M | 0.8% | $451.51 | 0 |
| 2025-Q2 | Increased | 247,434 | +0.4% | $120.5M | 0.9% | $557.82 | 42 |
| 2025-Q1 | Increased | 246,351 | +1.7% | $151.6M | 1.1% | $603.50 | 49 |
| 2024-Q4 | Increased | 242,172 | +10.0% | $128.3M | 0.9% | $525.44 | 47 |
| 2024-Q3 | Decreased | 220,067 | -0.6% | $132.3M | 0.9% | $595.79 | 0 |
| 2024-Q2 | Increased | 221,440 | +5.3% | $120.1M | 0.9% | $539.17 | 45 |